Facebook Pixel Bharat Forge stock rides global demand rebound for trucks, defence spend boom | Business Standard - newspaper - Read this story on Magzter.com

Try GOLD - Free

Bharat Forge stock rides global demand rebound for trucks, defence spend boom

Business Standard

|

March 09, 2026

The stock of auto component major Bharat Forge hit fresh all-time highs on Friday, supported by multiple triggers across its key business segments.

- RAM PRASAD SAHU

Bharat Forge stock rides global demand rebound for trucks, defence spend boom

The stock has been the top gainer in the BSE 200 index over the past month, rising 24 percent during this period.

The rally has been driven by a recovery in Class 8 truck demand in the US, strong commercial vehicle (CV) demand in the Indian market, improving prospects in the oil and gas segment, and expanding opportunities in the defence space.

However, the sharp gains of about 68 per cent over the past six months have pushed valuations into premium territory. At the current price, the stock is trading at more than 46 times its FY27 earnings estimates.

‘The immediate trigger for the recent surge has been sales of heavy trucks (Class 8) in the key North American market. Preliminary net orders jumped 47 percent month-on-month and 159 per cent year-on-year to 47,200 units. This marks the highest level in the past three and a half years and the third consecutive month of order growth exceeding 20 per cent.

MORE STORIES FROM Business Standard

Business Standard

Nalco urges Odisha govt to expedite land handover process for ‘30K cr projects

Navratna central public-sector enterprise (CPSE) Nalco has requested the Odisha government to expedite the land handover process for its 30,000 crore expansion projects that will boost capacity and help it achieve the Maharatna status by 2030.

time to read

1 mins

March 10, 2026

Business Standard

Women-led startups saw 9% funding drop in 2025

Female labour participation just 42%, among lowest in G20: Axis Bank study

time to read

3 mins

March 10, 2026

Business Standard

Business Standard

How India can kick the West Asian oil habit

Increasing the use of alternative fuels like ethanol could be one way out

time to read

6 mins

March 10, 2026

Business Standard

India’s T20 WC win brings new stars to brand crease

\"Sachin Tendulkar carried Indian cricket on his shoulders for 21 years.

time to read

3 mins

March 10, 2026

Business Standard

UBS downgrades OMCs as oil crosses $100/bbl

The recent rally in crude prices and refining margins create a sense of déjà vu, UBS said, mirroring the 2022 oil market disruption.

time to read

1 min

March 10, 2026

Business Standard

LIC drove 18% rise in life insurers’ NBP in Feb

New business premium of life insurance companies grew 18 per cent year-on-year (Y-o-Y) to ₹35,417 crore in February, driven by robust growth at the state-owned Life Insurance Corporation of India (LIC) due to a favourable base.

time to read

1 mins

March 10, 2026

Business Standard

Why India needs Russian oil

India's oil security is becoming increasingly fragile. Over 80 per cent of its crude imports come from just two suppliers — West Asia and Russia — both now facing geopolitical stress. In this environment, resuming full purchases of Russian oil may not be a choice but a necessity. Here are eight reasons why.

time to read

3 mins

March 10, 2026

Business Standard

India, Uzbekistan launch pharma-nutra corridor

India and Uzbekistan on Monday launched a structured pharmaceutical and nutraceutical trade corridor aimed at expanding access to the Commonwealth of Independent States (CIS) and the wider Eurasian healthcare market, estimated at $7-10 billion.

time to read

1 min

March 10, 2026

Business Standard

Business Standard

A clear derating

Markets risk underperformance if we don’t regain our growth credentials

time to read

5 mins

March 10, 2026

Business Standard

Delhi HC allows Dr Reddy’s to make semaglutide for export

A division Bench of the Delhi High Court on Monday affirmed a single-judge Bench’s order allowing pharmaceutical company Dr Reddy’s Laboratories to manufacture the diabetes and weight-management drug semaglutide in India for export to jurisdictions where Danish drugmaker Novo Nordisk does not have patent protection.

time to read

2 mins

March 10, 2026

Listen

Translate

Share

-
+

Change font size